Dr John Deadman (Senior Vice President Chemistry)

Dr Deadman obtained his Ph D in 1989 from the Institute of Cancer Research, London. Dr Deadman has more than twelve years experience in medicinal chemistry, drug design, and formulation/manufacturing aspects, first at the Thrombosis Research Institute and then as Head of Chemistry at Trigen, where he directed a program from discovery through to Phase II clinical trials. He is the author of more than 30 research papers and five patents. Dr Deadman moved to Amrad as Head of Chemistry in 2003 and now holds the position of Senior Vice President Chemistry at Avexa.